Linda, pretending to be inebriated
On our Norwegian cruise
I have long harbored mixed feelings about the French. Not only do they eat all manner of slimy invertebrates
and settle their important political issues by rioting; they refuse to use
English under any circumstances.
However: they do turn out wonderful – if expensive – wines. Now I report on something else admirable – and French.
I have mentioned in several blogs how the science of
applying immunotherapy to solid tumors has lagged. Well, a French outfit named Transgene has
taken up the challenge. They have just
received a go-ahead from our FDA for a Phase 1 clinical trial, which they will
finance. They apparently use a virus to
deliver their juice to the tumor. Every
other aspect of the thing is far out of reach of my aged brain.
Whatever, this must be big stuff because it was offered to
the public by three separate agencies (below).
Read ‘em and tell me how this works.
No comments:
Post a Comment